Ramos-Castañeda JA, Ruano-Ravina A, Barbosa-Lorenzo R, Paillier-Gonzalez JE, Saldaña-Campos JC, Salinas DF, et al. Mortality due to KPC carbapenemase-producing Klebsiella pneumoniae infections: systematic review and meta-analysis. J Infect. 2018;76:438–48.

PubMed  Google Scholar 

Munoz-Price LS, Poirel L, Bonomo RA, Schwaber MJ, Daikos GL, Cormican M, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013;13:785–96.

PubMed  PubMed Central  Google Scholar 

Cano A, Gutiérrez-Gutiérrez B, Machuca I, Gracia-Ahufinger I, Pérez-Nadales E, Causse M, et al. Risks of infection and mortality among patients colonized with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: validation of scores and proposal for management. Clin Infect Dis. 2018;66:1204–10.

PubMed  Google Scholar 

Tumbarello M, Viale P, Viscoli C, Trecarichi EM, Tumietto F, Marchese A, et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clin Infect Dis. 2012;55:943–50.

CAS  PubMed  Google Scholar 

Pérez-Nadales E, Natera AM, Recio-Rufián M, Guzmán-Puche J, Marín-Sanz JA, Martín-Pérez C, et al. Prognostic significance of the relative load of KPC-producing Klebsiella pneumoniae within the intestinal microbiota in a prospective cohort of colonized patients. Microbiol Spectr. 2022;10(4):e0272821.

Langford BJ, So M, Raybardhan S, Leung V, Soucy JPR, Westwood D, et al. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Clin Microbiol Infect. 2021;27:520–31.

CAS  PubMed  PubMed Central  Google Scholar 

Al-Hadidi SH, Alhussain H, Abdel Hadi H, Johar A, Yassine HM, Al Thani AA, et al. The spectrum of antibiotic prescribing during the COVID-19 pandemic: a systematic literature review. Microb Drug Resist. 2021;27:1705–25.

CAS  PubMed  PubMed Central  Google Scholar 

Afshinnekoo E, Bhattacharya C, Burguete-García A, Castro-Nallar E, Deng Y, Desnues C, et al. COVID-19 drug practices risk antimicrobial resistance evolution. Lancet Microbe. 2021;2:e135–6.

CAS  PubMed  PubMed Central  Google Scholar 

Abelenda-Alonso G, Padullés A, Rombauts A, Gudiol C, Pujol M, Alvarez-Pouso C, et al. Antibiotic prescription during the COVID-19 pandemic: a biphasic pattern. Infect Control Hosp Epidemiol. 2020;41:1371–2.

PubMed  Google Scholar 

Allel K, Peters A, Conejeros J, Martínez JRW, Spencer-Sandino M, Riquelme-Neira R, et al. Antibiotic consumption during the coronavirus disease 2019 pandemic and emergence of carbapenemase-producing Klebsiella pneumoniae lineages among inpatients in a Chilean hospital: a time-series study and phylogenomic analysis. Clin Infect Dis. 2023;77:S20–8.

PubMed  PubMed Central  Google Scholar 

Sellera FP, Lincopan N, Fuentes-Castillo D, Stehling EG, Furlan JPR. Rapid evolution of pan-β-lactam resistance in Enterobacterales co-producing KPC and NDM: insights from global genomic analysis after the COVID-19 pandemic. Lancet Microbe. 2024;5:e412–3. Available from: https://www.sciencedirect.com/science/article/pii/S2666524724000181. Cited 16 May 2025.

Vásquez-Ponce F, Vianello M, Becerra J, Pariona JGM, Dantas K, Melocco G, et al. Global epidemiological trend of Klebsiella pneumoniae ST340: emergence of subclade KL15 co-producing K. pneumoniae carbapenemase-2 and New Delhi metallo-β-lactamase-7 in the Americas. Lancet Microbe. 2025;6:100990. Available from: https://www.sciencedirect.com/science/article/pii/S2666524724002581. Cited 16 May 2025.

Jiang J, Wang L, Hu Y, Chen X, Li P, Zhang J, et al. Global emergence of Carbapenem-resistant Hypervirulent Klebsiella pneumoniae driven by an IncFIIK34 KPC-2 plasmid. EBioMedicine. 2025;113:105627. Available from: https://www.thelancet.com/action/showFullText?pii=S2352396425000714. Cited 16 May 2025.

López-Cerero L, Egea P, Gracia-Ahufinger I, González-Padilla M, Rodríguez-López F, Rodríguez-Baño J, et al. Characterisation of the first ongoing outbreak due to KPC-3-producing Klebsiella pneumoniae (ST512) in Spain. Int J Antimicrob Agents. 2014;44:538–40.

PubMed  Google Scholar 

European Centre for Disease Prevention and Control (ECDC). Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals – protocol version 6.1. ECDC PPS 2022–2023. 2022.

Cardoso T, Almeida M, Friedman ND, Aragão I, Costa-Pereira A, Sarmento AE, et al. Classification of healthcare-associated infection: A systematic review 10 years after the first proposal. BMC Med. 2014;12. Available from: https://pubmed.ncbi.nlm.nih.gov/24597462/. Cited 13 May 2025.

Deborah Friedman N, Levit D, Taleb E, Marcus G, Michaeli L, Broide M, et al. Towards a Definition for Health Care–Associated Infection. Open Forum Infect Dis. 2018;5. Available from: https://doi.org/10.1093/ofid/ofy116. Cited 13 May 2025.

Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, et al. Health care-associated bloodstream infections in adults: A reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137:791–7. Available from: https://pubmed.ncbi.nlm.nih.gov/12435215/. Cited 13 May 2025.

Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.

CAS  PubMed  Google Scholar 

Singer M, Deutschman CS, Seymour C, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801–10.

CAS  PubMed  PubMed Central  Google Scholar 

McCabe WR, Jackson GG. Gram-negative bacteremia: II. clinical, laboratory, and therapeutic observations. Arch Intern Med. 1962;110:856–64.

Google Scholar 

Gutiérrez-Gutiérrez B, Salamanca E, de Cueto M, Pascual A, Rodríguez-Baño J, Hsueh PR, et al. A predictive model of mortality in patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae. Mayo Clin Proc. 2016;91:1362–71.

PubMed  Google Scholar 

López-Viñau T, Peñalva G, García-Martínez L, Castón JJ, Muñoz-Rosa M, Cano Á, et al. Impact of an antimicrobial stewardship program on the incidence of carbapenem-resistant gram-negative bacilli: an interrupted time-series analysis. Antibiotics. 2021. https://doi.org/10.3390/antibiotics10050586.

Article  PubMed  PubMed Central  Google Scholar 

Molina J, Peñalva G, Gil-Navarro MV, Praena J, Lepe JA, Pérez-Moreno MA, et al. Long-term impact of an educational antimicrobial stewardship program on hospital-acquired candidemia and multidrug-resistant bloodstream infections: a quasi-experimental study of interrupted time-series analysis. Clin Infect Dis. 2017;65:1992–9.

PubMed  Google Scholar 

Peñalva G, Fernández-Urrusuno R, Turmo JM, Hernández-Soto R, Pajares I, Carrión L, et al. Long-term impact of an educational antimicrobial stewardship programme in primary care on infections caused by extended-spectrum β-lactamase-producing Escherichia coli in the community: an interrupted time-series analysis. Lancet Infect Dis. 2020;20:199–207.

PubMed  Google Scholar 

López-Viñau T, Muñoz-Rosa M, Ruiz-Lara LM, García-Martínez L, Machuca I, Gracia-Ahufinger I, et al. Long-term clinical and ecological impact of an antimicrobial stewardship program on the incidence of carbapenem-resistant Klebsiella pneumoniae infections in a high-endemic hospital. Antibiotics. 2024. https://doi.org/10.3390/antibiotics13090792.

Article  PubMed  PubMed Central  Google Scholar 

Romero Thomas G, Corso A, Pasterán F, Shal J, Sosa A, Pillonetto M, et al. Increased detection of carbapenemase-producing Enterobacterales bacteria in Latin America and the Caribbean during the COVID-19 pandemic. Emerg Infect Dis. 2022;28:E1-8.

Google Scholar 

Sulayyim HJ Al, Ismail R, Hamid A Al, Ghafar NA. Antibiotic resistance during COVID-19: a systematic review. Int J Environ Res Public Health. 2022;19(19):11931.

Baker MA, Sands KE, Huang SS, Kleinman K, Septimus EJ, Varma N, et al. The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections. Clin Infect Dis. 2022;74:1748–54.

CAS  PubMed  Google Scholar 

Haddad N, Zeenny RM, El Halabi C, Abdallah T, El Helou R, Zahreddine NK, et al. The experience of an antimicrobial stewardship program and antibiotic consumption and resistance trends during the COVID-19 pandemic at a tertiary care center in Beirut. J Infect Public Health. 2024;17:254–62.

PubMed  Google Scholar 

Reffat N, Schwei RJ, Griffin M, Pop-Vicas A, Schulz LT, Pulia MS. A scoping review of bacterial resistance among inpatients amidst the COVID-19 pandemic. J Glob Antimicrob Resist. 2024;38:49–65.

CAS  PubMed  PubMed Central  Google Scholar 

Li W, Yang X, Liu C, Liu X, Shi L, Zeng Y, et al. Multiple impacts of the COVID-19 pandemic and antimicrobial stewardship on antimicrobial resistance in nosocomial infections: an interrupted time series analysis. Front Public Health. 2024. https://doi.org/10.3389/fpubh.2024.1419344.

Article  PubMed  PubMed Central  Google Scholar 

Bizri AR, El-Fattah AA, Bazaraa HM, Al Ramahi JW, Matar M, Ali RAN, et al. Antimicrobial resistance landscape and COVID-19 impact in Egypt, Iraq, Jordan, and Lebanon: a survey-based study and expert opinion. PLoS One. 2023. https://doi.org/10.1371/journal.pone.0288550.

Article  PubMed  PubMed Central  Google Scholar 

Cireșă A, Tălăpan D, Vasile CC, Popescu C, Popescu GA. Evolution of antimicrobial resistance in Klebsiella pneumoniae over 3 years (2019–2021) in a tertiary hospital in Bucharest, Romania. Antibiotics (Basel). 2024. https://doi.org/10.3390/antibiotics13050431.

Article  PubMed  Google Scholar 

Chatterjee N, Nirwan PK, Srivastava S, Rati R, Sharma L, Sharma P, et al. Trends in carbapenem resistance in pre-COVID and COVID times in a tertiary care hospital in North India. Ann Clin Microbiol Antimicrob. 2023. https://doi.org/10.1186/s12941-022-00549-9.

Article  PubMed  PubMed Central  Google Scholar 

Vaughn VM, Gandhi TN, Petty LA, Patel PK, Prescott HC, Malani AN, et al. Empiric antibacterial therapy and community-onset bacterial coinfection in patients hospitalized with coronavirus disease 2019 (COVID-19): a multi-hospital cohort study. Clin Infect Dis. 2021;72:E533–41.

CAS  PubMed  Google Scholar 

Grasselli G, Pesenti A, Cecconi M. Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response. JAMA. 2020;323:1545–6.

CAS  PubMed  Google Scholar 

Chang HC, Chang CH, Tien KL, Tai CH, Lin LM, Lee TF, et al. Impact of coronavirus disease 2019 (COVID-19) on antimicrobial resistance among major pathogens causing healthcare-associated infection. J Formos Med Assoc. 2024;123:123–32.

CAS  PubMed  Google Scholar 

Pascale R, Bussini L, Gaibani P, Bovo F, Fornaro G, Lombardo D, et al. Carbapenem-resistant bacteria in an intensive care unit during the coronavirus disease 2019 (COVID-19) pandemic: a multicenter before-and-after cross-sectional study. Infect Control Hosp Epidemiol. 2022;43:461–6.

PubMed  Google Scholar 

Marchaim D, Gottesman T, Schwartz O, Korem M, Maor Y, Rahav G, et al. National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by Enterobacteriaceae producing extended-spectrum β-lactamases. Antimicrob Agents Chemother. 2010;54:5099–104. Available from: https://pubmed.ncbi.nlm.nih.gov/20837757/. Cited 19 May 2025.

Salamanca-Rivera E, Palacios-Baena ZR, Cañada JE, Moure Z, Pérez-Vázquez M, Calvo-Montes J, et al. Epidemiological and clinical characterization of community, healthcare-associated and nosocomial colonization and infection due to carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in Spain. Infection. 2024;52:2231-40. Available from: